A detailed history of Seven Mile Advisory transactions in Amgen Inc stock. As of the latest transaction made, Seven Mile Advisory holds 852 shares of AMGN stock, worth $272,035. This represents 0.2% of its overall portfolio holdings.

Number of Shares
852
Previous 739 15.29%
Holding current value
$272,035
Previous $210 Million 26.7%
% of portfolio
0.2%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $29,690 - $36,082
113 Added 15.29%
852 $266 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $4,301 - $5,192
16 Added 2.21%
739 $210 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $15,342 - $17,307
-60 Reduced 7.66%
723 $208 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $171,202 - $212,553
783 New
783 $210 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.